Comparision of efficacy and safety of 0.03% and 0.1% tacrolimus ointment in children with vernal keratoconjunctivitis

BACKGROUND: Topical immunosuppressants such as tacrolimus in different concentrations are a breakthrough in the management of recalcitrant vernal keratoconjunctivitis (VKC); however, there is a lacks of comparative studies to guide their use in VKC management. OBJECTIVE: To compare the efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Saha, Bhawesh Chandra, Kumari, Rashmi, Ambasta, Anita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226287/
https://www.ncbi.nlm.nih.gov/pubmed/37255622
http://dx.doi.org/10.1177/25158414231173532

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10226287/
https://www.ncbi.nlm.nih.gov/pubmed/37255622
http://dx.doi.org/10.1177/25158414231173532

Ejemplares similares